AstraZeneca Plc achieved higher sales and pre-tax profit in the 2009 second quarter, and at the same time moved three late-stage products into registration. The UK-based multinational has also raised its earnings-per-share guidance for the year.
AstraZeneca Plc achieved higher sales and pre-tax profit in the 2009 second quarter, and at the same time moved three late-stage products into registration. The UK-based multinational has also raised its earnings-per-share guidance for the year.